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3. Immunoprecipitation shows that EWS via its RBD, but not EWS-Fli1, interacts
with the 40S small ribosomal subunit
2. EWS represses luciferase translation via its RBDIII. Materials and Results :
1. FET proteins repress luciferase translation in HeLa and HEK293 cells
I. Introduction :
The FET/TET proteins, which include TLS/FUS, EWS, and TAF15 are RNA- and DNA-binding proteins, with functions in transcription and RNA processing. Each of these proteins harbors a
potent N-terminal transcriptional activation domain (the EAD) that is revealed in the context of oncogenic EWS-fusions and a C-terminal RNA-Binding Domain (RBD) (fig.1) implicated in
different aspects of RNA biogenesis and being the most conserved region within the TET protein family (fig.2).
The FET members are involved in chromosomal translocations in which the 5' part of human FET genes is fused to the 3' region of genes encoding potent transcription factors, including
members of the Erg transcription factor family (ERG, Fli1 and FEV). FET-Erg fusions have been associated with Ewing's sarcoma (ES) family tumors and acute myeloid leukemia and a
plethora of evidence leaves little doubt that these fusions are essential to the development of these malignancies. Because they include the C-terminal half of Erg proteins, which contains the
ETS DNA-binding domain, fused to the amino-terminal portion of FET proteins, which behaves as a potent transcription activation domain, FET-Erg fusions have mostly been studied as
oncogenic transcription factors. Among these fusions, EWS-Fli1 is found in ~85% of the Ewing sarcomas (fig.3).
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Figure 1. The TET/FET protein family contains three members TAF15,
EWS and TLS/FUS. TETs are containing an N-terminal region referred to
here as EWS-activation domain (EAD, purple boxes) and a C-terminal
RNA-binding domain (RBD). The TET RBD contains two elements (an
RRM and Arg/Gly rich RGG boxes) and a C2–C2 zinc finger (Z).
Figure 2. TET/FET proteins are highly related. Amino
acid similarity and identity compared over the whole
protein and within the RBD for TLS, EWS and TAF15.
Figure 3. The reciprocal
translocation between
chromosomes 11 and 22 results in
the formation of an EWS-Fli1
fusion gene on the abnormal
chromosome 22 that codes for a
chimeric transcription factor with
the N-terminal transcriptional
regulatory domain deriving from
EWS and the ETS -specific DNA-






































































































































In this project, we will take advantage of recent findings from our laboratory and will assess the provocative hypothesis that important post-transcriptional functions of EWS protein, in


























































IV. Discussion and Conclusion :
A tethering approach and RT-qPCR analysis showed that FET proteins are implicated in the
repression of translation. Focusing on the EWS member, we found that its RNA Binding Domain
(RBD) is the domain implicated in translational repression. Our findings also suggest that
repression of translation by EWS requires its interaction with the 40S small ribosomal subunit.
Further experiments will further characterize the underlying molecular mechanism. Interestingly,
the EWS-Fli1 fusion protein lacks the RBD and consequently has no effect on translation.
In conclusion, our observations have uncovered unsuspected functions for EWS in




Figure 4. Tethering of FET proteins to the 3'-UTR of luciferase mRNA reporter in HeLa and
HEK293 cells. (a) Principle of tethering assay: FET proteins (X = FUS, EWS or TAF15) fused to
the tethering protein, MS2-Coat Protein, recognize the RNA tag sequence in the 3’-UTR of the
luciferase mRNA reporter with high specificity and affinity. The function of the tethered protein is
assayed using the Dual-Luciferase Reporter (DLR) Assay system. (b,c) Tethered FET proteins
reduce luciferase expression (P= luciferase Protein level) and have no effect on steady-state levels of
the mRNA reporter, as detected by RT-qPCR in HeLa (b) and HEK293 cells (c). (d,e) Western blot
analysis of FET proteins expression in HeLa (d) and HEK293 cells (e).
Figure 5. Tethering of EWS and its domains (EAD and RBD) to the 3'-UTR of luciferase mRNA
reporter in HeLa cells. (a) Tethered EWS and its RBD reduce luciferase expression (P = luciferase
Protein level) and have no effect on steady-state levels of the luciferase mRNA reporter, while tethered
EAD leads to only a marginal decrease in luciferase activity. (b) Western blot analysis of EWS and its
domains proteins expression in HeLa cells.
Figure 6. Immunoprecipitation (IP) of FLAG-tagged FET members
(a), Flag-tagged EWS and its FLAG-tagged domains (b), Flag-tagged
EWS-Fi1 fusion (c) and anti-Flag, anti-RPS6 and anti-RPL26 western
blotting. Samples are lysates from HeLa cells transfected with FLAG-
tagged FET members (a), Flag-tagged EWS and its Flag-tagged
domains (b), Flag-tagged EWS-Fi1 fusion (c). Immunoprecipitation
(IP) of FLAG-tagged EWS and anti-FLAG, anti-RPS6 and anti-
RPL26 (d). Samples are non-treated (-RNase) or RNase-A treated
































































Figure 7. Tethering of EWS-Fli1 to the 3'-UTR of luciferase mRNA reporter in HeLa cells. (a)
Tethered EWS-Fli1 has no effect on luciferase expression nor on steady-state levels of the mRNA
reporter. (b) Western blot analysis of EWS-Fli1 protein expression in HeLa cells.
(a) (b)
